Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva | DOI[10.1007/s11306-012-0464-y] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT4219 | Individual Protein | Choline acetylase | Homo sapiens | Ki | = | 200000 | nM | 7310833 |
NPT2 | Others | Unspecified | IC50 | > | 1600000 | nM | 12672248 | |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | IC50 | > | 1600000 | nM | 11931626 |
NPT142 | Individual Protein | Fatty acid binding protein adipocyte | Homo sapiens | Kd | = | 150 | nM | 17502136 |
NPT142 | Individual Protein | Fatty acid binding protein adipocyte | Homo sapiens | Ki | = | 1000 | nM | 17502136 |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Kd | = | 1100 | nM | 19954984 |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Kd | = | 4800 | nM | 19954984 |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Kd | = | 1800 | nM | 19954984 |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Kd | = | 10000 | nM | 19954984 |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Kd | = | 4300 | nM | 19954984 |
NPT2 | Others | Unspecified | Kd | = | 1400 | nM | 19954984 | |
NPT2 | Others | Unspecified | Kd | = | 5200 | nM | 19954984 | |
NPT2 | Others | Unspecified | Kd | = | 3200 | nM | 19954984 | |
NPT2 | Others | Unspecified | Kd | = | 6700 | nM | 19954984 | |
NPT2 | Others | Unspecified | Kd | = | 4500 | nM | 19954984 | |
NPT77 | Individual Protein | Transthyretin | Homo sapiens | Activity | = | 44 | % | 19954984 |
NPT2 | Others | Unspecified | IC50 | = | 19470 | nM | PubChem BioAssay data set | |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 12995.3 | nM | PubChem BioAssay data set | ||
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2511.9 | nM | PubChem BioAssay data set | ||
NPT917 | Individual Protein | Dengue virus type 2 NS3 protein | Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT1371 | Individual Protein | Cyclin-dependent kinase 2 | Homo sapiens | Kd | = | 37000 | nM | 22004849 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 20596.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 16360.1 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 17782.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | 15003 | nM | PubChem BioAssay data set | |
NPT1371 | Individual Protein | Cyclin-dependent kinase 2 | Homo sapiens | IC50 | = | 91000 | nM | 10.1039/C4MD00364K |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC328590 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.825 | Intermediate Similarity | NPC79618 |
0.7951 | Intermediate Similarity | NPC434 |
0.75 | Intermediate Similarity | NPC473429 |
0.7167 | Intermediate Similarity | NPC108800 |
0.6923 | Remote Similarity | NPC302790 |
0.673 | Remote Similarity | NPC474791 |
0.6643 | Remote Similarity | NPC475915 |
0.6639 | Remote Similarity | NPC107135 |
0.6615 | Remote Similarity | NPC328877 |
0.6583 | Remote Similarity | NPC229477 |
0.6562 | Remote Similarity | NPC323726 |
0.6562 | Remote Similarity | NPC469897 |
0.6513 | Remote Similarity | NPC312092 |
0.6504 | Remote Similarity | NPC176858 |
0.6503 | Remote Similarity | NPC192533 |
0.6475 | Remote Similarity | NPC43655 |
0.6456 | Remote Similarity | NPC322283 |
0.6452 | Remote Similarity | NPC191444 |
0.6446 | Remote Similarity | NPC288430 |
0.6364 | Remote Similarity | NPC268534 |
0.6336 | Remote Similarity | NPC291610 |
0.6333 | Remote Similarity | NPC473930 |
0.6259 | Remote Similarity | NPC250361 |
0.6241 | Remote Similarity | NPC313449 |
0.624 | Remote Similarity | NPC315403 |
0.619 | Remote Similarity | NPC252794 |
0.6174 | Remote Similarity | NPC473417 |
0.6174 | Remote Similarity | NPC473762 |
0.6159 | Remote Similarity | NPC475450 |
0.6154 | Remote Similarity | NPC54102 |
0.6154 | Remote Similarity | NPC162689 |
0.6149 | Remote Similarity | NPC476140 |
0.6133 | Remote Similarity | NPC473587 |
0.6125 | Remote Similarity | NPC477134 |
0.6124 | Remote Similarity | NPC329430 |
0.6111 | Remote Similarity | NPC279385 |
0.6111 | Remote Similarity | NPC179605 |
0.6107 | Remote Similarity | NPC209389 |
0.6099 | Remote Similarity | NPC288232 |
0.6093 | Remote Similarity | NPC475428 |
0.6071 | Remote Similarity | NPC296163 |
0.6071 | Remote Similarity | NPC187036 |
0.6071 | Remote Similarity | NPC314141 |
0.6069 | Remote Similarity | NPC103292 |
0.6053 | Remote Similarity | NPC179365 |
0.604 | Remote Similarity | NPC145754 |
0.6032 | Remote Similarity | NPC111233 |
0.6032 | Remote Similarity | NPC30445 |
0.6014 | Remote Similarity | NPC122718 |
0.6014 | Remote Similarity | NPC192209 |
0.5987 | Remote Similarity | NPC282398 |
0.5986 | Remote Similarity | NPC41174 |
0.5964 | Remote Similarity | NPC316910 |
0.5959 | Remote Similarity | NPC257490 |
0.5952 | Remote Similarity | NPC262295 |
0.5951 | Remote Similarity | NPC33421 |
0.5938 | Remote Similarity | NPC78154 |
0.5926 | Remote Similarity | NPC109787 |
0.5924 | Remote Similarity | NPC169433 |
0.5909 | Remote Similarity | NPC313352 |
0.5904 | Remote Similarity | NPC184476 |
0.5903 | Remote Similarity | NPC148140 |
0.5887 | Remote Similarity | NPC134825 |
0.5882 | Remote Similarity | NPC22079 |
0.5875 | Remote Similarity | NPC311330 |
0.5873 | Remote Similarity | NPC258046 |
0.5862 | Remote Similarity | NPC81561 |
0.5859 | Remote Similarity | NPC173991 |
0.5852 | Remote Similarity | NPC239854 |
0.584 | Remote Similarity | NPC169016 |
0.5839 | Remote Similarity | NPC242556 |
0.5833 | Remote Similarity | NPC41257 |
0.5833 | Remote Similarity | NPC313673 |
0.5811 | Remote Similarity | NPC39818 |
0.5809 | Remote Similarity | NPC474430 |
0.5802 | Remote Similarity | NPC264589 |
0.5799 | Remote Similarity | NPC215584 |
0.5799 | Remote Similarity | NPC44773 |
0.5774 | Remote Similarity | NPC286427 |
0.5772 | Remote Similarity | NPC254698 |
0.5769 | Remote Similarity | NPC470926 |
0.5758 | Remote Similarity | NPC148592 |
0.5752 | Remote Similarity | NPC9856 |
0.5752 | Remote Similarity | NPC194562 |
0.575 | Remote Similarity | NPC284635 |
0.5743 | Remote Similarity | NPC215519 |
0.574 | Remote Similarity | NPC318065 |
0.574 | Remote Similarity | NPC56765 |
0.574 | Remote Similarity | NPC206819 |
0.5732 | Remote Similarity | NPC198988 |
0.5724 | Remote Similarity | NPC476950 |
0.5714 | Remote Similarity | NPC291962 |
0.5714 | Remote Similarity | NPC177684 |
0.5697 | Remote Similarity | NPC124005 |
0.5697 | Remote Similarity | NPC37548 |
0.5696 | Remote Similarity | NPC325252 |
0.5694 | Remote Similarity | NPC205652 |
0.569 | Remote Similarity | NPC194411 |
0.5689 | Remote Similarity | NPC161108 |
0.5687 | Remote Similarity | NPC88097 |
0.5679 | Remote Similarity | NPC477977 |
0.5676 | Remote Similarity | NPC258531 |
0.5676 | Remote Similarity | NPC161956 |
0.5676 | Remote Similarity | NPC112373 |
0.5671 | Remote Similarity | NPC288838 |
0.566 | Remote Similarity | NPC314102 |
0.566 | Remote Similarity | NPC251722 |
0.5655 | Remote Similarity | NPC218710 |
0.5652 | Remote Similarity | NPC59084 |
0.5652 | Remote Similarity | NPC2949 |
0.5652 | Remote Similarity | NPC115611 |
0.565 | Remote Similarity | NPC473432 |
0.5646 | Remote Similarity | NPC264580 |
0.564 | Remote Similarity | NPC162799 |
0.5636 | Remote Similarity | NPC471957 |
0.5629 | Remote Similarity | NPC216713 |
0.5625 | Remote Similarity | NPC130251 |
0.5618 | Remote Similarity | NPC68354 |
0.5617 | Remote Similarity | NPC478040 |
0.5617 | Remote Similarity | NPC473868 |
0.5617 | Remote Similarity | NPC63157 |
0.5616 | Remote Similarity | NPC147957 |
0.5608 | Remote Similarity | NPC226143 |
0.56 | Remote Similarity | NPC280548 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC328590 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7929 | Intermediate Similarity | NPD5518 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD5606 | Discontinued |
0.7372 | Intermediate Similarity | NPD572 | Clinical (unspecified phase) |
0.7324 | Intermediate Similarity | NPD6821 | Approved |
0.7255 | Intermediate Similarity | NPD6574 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD6820 | Approved |
0.7234 | Intermediate Similarity | NPD6822 | Approved |
0.7075 | Intermediate Similarity | NPD1938 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD1590 | Approved |
0.6948 | Remote Similarity | NPD1854 | Approved |
0.6894 | Remote Similarity | NPD2038 | Approved |
0.6894 | Remote Similarity | NPD2039 | Approved |
0.6879 | Remote Similarity | NPD3240 | Phase 2 |
0.6795 | Remote Similarity | NPD8354 | Approved |
0.6767 | Remote Similarity | NPD3001 | Approved |
0.6767 | Remote Similarity | NPD2999 | Approved |
0.6765 | Remote Similarity | NPD1596 | Approved |
0.6765 | Remote Similarity | NPD1312 | Approved |
0.6748 | Remote Similarity | NPD5531 | Discontinued |
0.6691 | Remote Similarity | NPD2338 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1311 | Approved |
0.6667 | Remote Similarity | NPD8355 | Approved |
0.6667 | Remote Similarity | NPD8353 | Approved |
0.6641 | Remote Similarity | NPD990 | Approved |
0.6641 | Remote Similarity | NPD993 | Approved |
0.6618 | Remote Similarity | NPD4674 | Clinical (unspecified phase) |
0.6617 | Remote Similarity | NPD1539 | Approved |
0.6617 | Remote Similarity | NPD4116 | Approved |
0.6581 | Remote Similarity | NPD1528 | Clinical (unspecified phase) |
0.6562 | Remote Similarity | NPD3784 | Discontinued |
0.6552 | Remote Similarity | NPD3011 | Approved |
0.6552 | Remote Similarity | NPD3012 | Approved |
0.6552 | Remote Similarity | NPD3008 | Approved |
0.6544 | Remote Similarity | NPD2913 | Approved |
0.6544 | Remote Similarity | NPD2914 | Approved |
0.6531 | Remote Similarity | NPD9485 | Approved |
0.6515 | Remote Similarity | NPD3546 | Approved |
0.6515 | Remote Similarity | NPD3545 | Approved |
0.6475 | Remote Similarity | NPD3005 | Phase 3 |
0.6466 | Remote Similarity | NPD4115 | Approved |
0.6466 | Remote Similarity | NPD5253 | Approved |
0.6466 | Remote Similarity | NPD4114 | Approved |
0.6446 | Remote Similarity | NPD5412 | Discontinued |
0.6438 | Remote Similarity | NPD1328 | Approved |
0.6406 | Remote Similarity | NPD716 | Approved |
0.6403 | Remote Similarity | NPD4660 | Discontinued |
0.6389 | Remote Similarity | NPD2938 | Approved |
0.6389 | Remote Similarity | NPD2871 | Approved |
0.6389 | Remote Similarity | NPD2940 | Approved |
0.6389 | Remote Similarity | NPD2870 | Approved |
0.6358 | Remote Similarity | NPD2145 | Clinical (unspecified phase) |
0.6346 | Remote Similarity | NPD7017 | Clinical (unspecified phase) |
0.6343 | Remote Similarity | NPD278 | Approved |
0.6343 | Remote Similarity | NPD2310 | Clinical (unspecified phase) |
0.6336 | Remote Similarity | NPD4735 | Approved |
0.6336 | Remote Similarity | NPD4734 | Approved |
0.6329 | Remote Similarity | NPD4644 | Clinical (unspecified phase) |
0.6301 | Remote Similarity | NPD1949 | Approved |
0.6301 | Remote Similarity | NPD1950 | Approved |
0.6301 | Remote Similarity | NPD3438 | Approved |
0.6294 | Remote Similarity | NPD3348 | Phase 2 |
0.6284 | Remote Similarity | NPD4019 | Clinical (unspecified phase) |
0.6275 | Remote Similarity | NPD1626 | Approved |
0.6269 | Remote Similarity | NPD261 | Approved |
0.6268 | Remote Similarity | NPD1306 | Clinical (unspecified phase) |
0.6259 | Remote Similarity | NPD5629 | Discontinued |
0.6258 | Remote Similarity | NPD6768 | Approved |
0.6257 | Remote Similarity | NPD4398 | Clinical (unspecified phase) |
0.6243 | Remote Similarity | NPD4399 | Phase 2 |
0.6242 | Remote Similarity | NPD5782 | Phase 3 |
0.6241 | Remote Similarity | NPD7481 | Approved |
0.6241 | Remote Similarity | NPD7480 | Approved |
0.624 | Remote Similarity | NPD9108 | Approved |
0.6228 | Remote Similarity | NPD4532 | Approved |
0.6228 | Remote Similarity | NPD4645 | Clinical (unspecified phase) |
0.6226 | Remote Similarity | NPD4888 | Discontinued |
0.622 | Remote Similarity | NPD1679 | Approved |
0.6218 | Remote Similarity | NPD1625 | Approved |
0.6214 | Remote Similarity | NPD202 | Clinical (unspecified phase) |
0.6212 | Remote Similarity | NPD4321 | Approved |
0.6211 | Remote Similarity | NPD1636 | Approved |
0.6209 | Remote Similarity | NPD4411 | Phase 1 |
0.6209 | Remote Similarity | NPD4410 | Clinical (unspecified phase) |
0.6207 | Remote Similarity | NPD964 | Approved |
0.6205 | Remote Similarity | NPD6275 | Clinical (unspecified phase) |
0.6202 | Remote Similarity | NPD3093 | Approved |
0.6197 | Remote Similarity | NPD5657 | Phase 3 |
0.619 | Remote Similarity | NPD5921 | Clinical (unspecified phase) |
0.6178 | Remote Similarity | NPD6506 | Clinical (unspecified phase) |
0.6174 | Remote Similarity | NPD4490 | Approved |
0.6174 | Remote Similarity | NPD4489 | Approved |
0.6163 | Remote Similarity | NPD5840 | Discontinued |
0.6148 | Remote Similarity | NPD423 | Phase 3 |
0.6139 | Remote Similarity | NPD5254 | Discontinued |
0.6138 | Remote Similarity | NPD2131 | Approved |
0.6135 | Remote Similarity | NPD7969 | Clinical (unspecified phase) |
0.6135 | Remote Similarity | NPD4045 | Phase 2 |
0.6135 | Remote Similarity | NPD4042 | Phase 2 |
0.6133 | Remote Similarity | NPD4300 | Clinical (unspecified phase) |
0.6131 | Remote Similarity | NPD7633 | Discontinued |
0.6124 | Remote Similarity | NPD5554 | Approved |
0.6122 | Remote Similarity | NPD3584 | Approved |
0.6122 | Remote Similarity | NPD3585 | Approved |
0.6119 | Remote Similarity | NPD4937 | Approved |
0.6119 | Remote Similarity | NPD4936 | Approved |
0.6118 | Remote Similarity | NPD5431 | Phase 2 |
0.6114 | Remote Similarity | NPD7848 | Approved |
0.6111 | Remote Similarity | NPD3957 | Phase 2 |
0.6111 | Remote Similarity | NPD3955 | Approved |
0.6111 | Remote Similarity | NPD3956 | Phase 3 |
0.6111 | Remote Similarity | NPD4641 | Discontinued |
0.6107 | Remote Similarity | NPD5442 | Approved |
0.6103 | Remote Similarity | NPD6299 | Approved |
0.6103 | Remote Similarity | NPD6300 | Approved |
0.6098 | Remote Similarity | NPD2748 | Clinical (unspecified phase) |
0.609 | Remote Similarity | NPD2750 | Approved |
0.6084 | Remote Similarity | NPD430 | Discontinued |
0.6081 | Remote Similarity | NPD6900 | Discontinued |
0.6077 | Remote Similarity | NPD2005 | Discontinued |
0.6071 | Remote Similarity | NPD5180 | Approved |
0.6071 | Remote Similarity | NPD5181 | Approved |
0.6071 | Remote Similarity | NPD5179 | Approved |
0.6069 | Remote Similarity | NPD4546 | Discontinued |
0.6067 | Remote Similarity | NPD2919 | Clinical (unspecified phase) |
0.6067 | Remote Similarity | NPD2918 | Clinical (unspecified phase) |
0.6067 | Remote Similarity | NPD8263 | Discontinued |
0.6065 | Remote Similarity | NPD1262 | Discovery |
0.6061 | Remote Similarity | NPD9353 | Approved |
0.6056 | Remote Similarity | NPD7845 | Approved |
0.6056 | Remote Similarity | NPD3484 | Approved |
0.6056 | Remote Similarity | NPD2467 | Approved |
0.6056 | Remote Similarity | NPD2473 | Clinical (unspecified phase) |
0.6056 | Remote Similarity | NPD3483 | Approved |
0.6056 | Remote Similarity | NPD2463 | Approved |
0.6056 | Remote Similarity | NPD2464 | Approved |
0.6056 | Remote Similarity | NPD7846 | Approved |
0.6053 | Remote Similarity | NPD1874 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD3943 | Clinical (unspecified phase) |
0.6043 | Remote Similarity | NPD3010 | Approved |
0.6043 | Remote Similarity | NPD3009 | Approved |
0.604 | Remote Similarity | NPD1560 | Clinical (unspecified phase) |
0.6037 | Remote Similarity | NPD7822 | Phase 1 |
0.6031 | Remote Similarity | NPD9352 | Approved |
0.6026 | Remote Similarity | NPD947 | Approved |
0.6026 | Remote Similarity | NPD5099 | Approved |
0.6026 | Remote Similarity | NPD5098 | Approved |
0.6022 | Remote Similarity | NPD917 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD299 | Phase 3 |
0.6014 | Remote Similarity | NPD2522 | Approved |
0.6014 | Remote Similarity | NPD4608 | Approved |
0.6014 | Remote Similarity | NPD4609 | Approved |
0.6014 | Remote Similarity | NPD2520 | Approved |
0.6014 | Remote Similarity | NPD3548 | Approved |
0.6 | Remote Similarity | NPD6342 | Discontinued |
0.6 | Remote Similarity | NPD5839 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD9188 | Approved |
0.6 | Remote Similarity | NPD6892 | Discontinued |
0.6 | Remote Similarity | NPD7563 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD5021 | Discontinued |
0.5988 | Remote Similarity | NPD1226 | Approved |
0.5988 | Remote Similarity | NPD1890 | Clinical (unspecified phase) |
0.5987 | Remote Similarity | NPD1953 | Discontinued |
0.5987 | Remote Similarity | NPD4468 | Approved |
0.5987 | Remote Similarity | NPD1222 | Discontinued |
0.5986 | Remote Similarity | NPD1720 | Phase 2 |
0.5986 | Remote Similarity | NPD2924 | Approved |
0.5986 | Remote Similarity | NPD2925 | Approved |
0.5986 | Remote Similarity | NPD1723 | Phase 2 |
0.5985 | Remote Similarity | NPD1824 | Discontinued |
0.5985 | Remote Similarity | NPD9304 | Approved |
0.5974 | Remote Similarity | NPD1410 | Phase 1 |
0.5974 | Remote Similarity | NPD1228 | Phase 2 |
0.5973 | Remote Similarity | NPD2840 | Approved |
0.5972 | Remote Similarity | NPD3954 | Approved |
0.5969 | Remote Similarity | NPD4405 | Approved |
0.5969 | Remote Similarity | NPD4408 | Approved |
0.5969 | Remote Similarity | NPD4407 | Approved |
0.5964 | Remote Similarity | NPD2330 | Approved |
0.596 | Remote Similarity | NPD5268 | Approved |
0.5954 | Remote Similarity | NPD3859 | Clinical (unspecified phase) |
0.5952 | Remote Similarity | NPD2385 | Clinical (unspecified phase) |
0.5949 | Remote Similarity | NPD3482 | Approved |
0.5946 | Remote Similarity | NPD1640 | Clinical (unspecified phase) |
0.5942 | Remote Similarity | NPD1721 | Clinical (unspecified phase) |
0.5941 | Remote Similarity | NPD1965 | Approved |
0.594 | Remote Similarity | NPD1946 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD3401 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD4509 | Discontinued |
0.5932 | Remote Similarity | NPD5106 | Approved |
0.5932 | Remote Similarity | NPD5105 | Approved |
0.5931 | Remote Similarity | NPD3499 | Approved |
0.5931 | Remote Similarity | NPD3498 | Approved |
0.5929 | Remote Similarity | NPD2521 | Approved |
0.5929 | Remote Similarity | NPD3566 | Approved |
0.5929 | Remote Similarity | NPD2519 | Approved |
0.5929 | Remote Similarity | NPD3036 | Approved |
0.5929 | Remote Similarity | NPD3565 | Approved |
0.5929 | Remote Similarity | NPD2518 | Approved |
0.5921 | Remote Similarity | NPD486 | Clinical (unspecified phase) |
0.5917 | Remote Similarity | NPD3829 | Clinical (unspecified phase) |
PubChem CID   | 1369 |
ChEMBL   | CHEMBL285527 |
ZINC   |
Molecular Weight:   | 299.06 |
ALogP:   | -0.9619 |
MLogP:   | 2.67 |
XLogP:   | 4.372 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 74.78 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |